Fresenius Medical Care AG & Co. KGaA R&D Expense Quarterly:

30.37M for March 31, 2013
View Full Chart

Fresenius Medical Care AG & Co. KGaA R&D Expense Quarterly Chart

    Fresenius Medical Care AG & Co. KGaA Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 30.37M
    Dec. 31, 2012 28.30M
    Sept. 30, 2012 27.87M
    June 30, 2012 26.94M
    March 31, 2012 28.52M
    Dec. 31, 2011 30.29M
    Sept. 30, 2011 27.61M
    June 30, 2011 26.78M
    March 31, 2011 26.15M
    Dec. 31, 2010 29.28M
    Sept. 30, 2010 22.79M
    June 30, 2010 21.37M
    March 31, 2010 23.09M
    Dec. 31, 2009 29.30M
    Sept. 30, 2009 22.66M
    June 30, 2009 18.96M
    March 31, 2009 22.90M
    Dec. 31, 2008 20.26M
    Sept. 30, 2008 20.21M
    June 30, 2008 20.65M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    FMS R&D Expense Quarterly Benchmarks

    Companies
    DaVita HealthCare Partners
    Baxter International 246.00M
    HCA

    FMS R&D Expense Quarterly Rankings

    Overall 96th percentile
    289 of 8002
    Sector 89th percentile
    72 of 684 in Healthcare
    Industry 97th percentile
    1 of 43 in Medical Care

    FMS R&D Expense Quarterly Range, Past 5 Years

    Minimum 18.96M Jun 2009
    Maximum 30.37M Mar 2013
    Average 25.21M